معرفی
Mario C. Deng is a Professor-in-Residence in the School of Medicine at the University of California Los Angeles (UCLA), where he has established himself as a leading researcher in cardiac transplantation and heart failure. His work focuses on developing molecular biomarkers to improve patient outcomes and personalize treatment approaches for heart transplant recipients.
Dr. Deng's research interests span multiple areas of cardiovascular medicine, with particular emphasis on:
- Heart transplantation and cardiac allograft rejection mechanisms
- Molecular and genomic biomarkers for rejection monitoring
- Mechanical circulatory support and its immunological implications
- Precision medicine approaches in heart failure management
- Multi-omics analysis for predicting post-transplant outcomes
- Cardiovascular complications of infectious diseases including COVID-19
Analysis of Dr. Deng's recent publications reveals a strong focus on translating molecular diagnostics into clinical practice. His work increasingly incorporates multi-dimensional approaches combining genomics, transcriptomics, and clinical data to develop more precise predictive models for heart transplant outcomes. A significant portion of his recent research investigates non-invasive biomarkers to replace or complement traditional endomyocardial biopsies in monitoring transplant patients.
Dr. Deng has received substantial research funding from the National Institutes of Health (NIH), including:
- Principal Investigator for "Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients" (NIH R01AI159946, 2021-2026)
- Co-Principal Investigator for "Multi-omic Biomarker Discovery and Validation in Heart Transplant Patient Populations" (NIH R01AI144522, 2020-2025)
- Principal Investigator for "Multidimensional Molecular Biomarkers of Multi-Organ Dysfunction after MCS Therapy" (NIH R21HL120040, 2014-2016)
- Co-Principal Investigator for "Systems Approach to Unraveling the Genetic Basis of Heart Failure" (NIH R01HL114437, 2013-2017)
Dr. Deng collaborates extensively with researchers across UCLA and other institutions, particularly in the fields of immunology, cardiology, and transplantation medicine. His work has significantly contributed to the development and validation of molecular diagnostic tools that are changing clinical practice in heart transplantation.
